Starsource Multitrade

Starsource Multitrade P/TBV

Pris til håndgribeligt bogført værdi (P/TBV) for Starsource Multitrade (506365.BO) pr. 17. okt. 2026 er 13,16. I foregående år var Pris til håndgribeligt bogført værdi (P/TBV) 1,29 — en ændring på 919,24 % (højere).

P/TBV

13,16

YoY

919,24%

Senest opdateret:

Pris til håndgribeligt bogført værdi (P/TBV) for Starsource Multitrade er 2026 13,16 . Pris til håndgribeligt bogført værdi (P/TBV) for Starsource Multitrade var 2025 1,29 . Det falder dermed med 919,24% højere sammenlignet med året før.

Starsource Multitrade P/TBV historik

  • 3 år

  • 10 år

  • 25 år

  • Maks

P/TBV
Dato
P/TBV
1. jan. 2019
1,64 INR
1. jan. 2020
1,58 INR
1. jan. 2021
1,54 INR
1. jan. 2022
1,47 INR
1. jan. 2023
1,46 INR
1. jan. 2024
1,33 INR
1. jan. 2025
1,29 INR
1. jan. 2026
13,16 INR
Starsource Multitrade P/TBV historik
ÅRP/TBVYoY
13,16+919,24%
1,29-2,60%
1,33-9,38%
1,46-0,41%
1,47-4,85%
1,54-2,27%
1,58-3,86%
1,64-2,00%
1,68-0,99%
1,69-63,35%
4,62+39,44%
3,31-5,29%
3,50—

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

Starsource Multitrade Aktieanalyse

Hvad laver Starsource Multitrade? Starsource Multitrade Ltd, identified by the ticker symbol 506365.BO and ISIN INE320M01019, is a corporate entity registered in India with its headquarters located in Mumbai, Maharashtra. The company was originally established through an initial public offering on January 2, 1995. While the specific sector and industry classifications are currently listed as not applicable, the company's operational history and strategic direction are closely tied to its former identity as Chemo Pharma Laboratories Ltd. This previous incarnation operated within the pharmaceutical industry, focusing on the development and distribution of healthcare products. However, the corporate landscape has shifted significantly, and the entity is no longer engaged in its original pharmaceutical activities. According to available information, the firm currently has no active operations within its traditional business lines. Instead, the organization is in a transitional phase, actively exploring new business opportunities to redefine its market presence. The strategic intent of the current management is to pivot away from pharmaceuticals and acquire businesses in the power and chemicals sectors. This move represents a substantial change in the company's core focus, aiming to diversify its portfolio and enter entirely different industrial segments. The company's official website, https://www.thechemopharmalaboratoriesltd.com/, reflects its historical branding, although the operational reality has evolved. Investors and stakeholders monitoring the company should note that the absence of current operations means that recent financial performance may not reflect traditional revenue streams associated with pharmaceutical manufacturing or sales. The focus is currently on strategic acquisitions and business development rather than organic growth from existing products. The transition from a pharmaceutical manufacturer to a holding or investment vehicle targeting power and chemical assets suggests a long-term restructuring plan. Until new acquisitions are finalized and integrated, the company remains in a state of exploration and preparation. The headquarters in Mumbai serves as the administrative center for these strategic discussions and future operational planning. The lack of a defined sector classification further underscores the company's current status as an entity in flux, waiting for new business units to be acquired and operationalized. This profile highlights the significant shift from its historical roots in healthcare to its current ambitions in energy and industrial chemicals, marking a distinct chapter in the company's corporate evolution. Starsource Multitrade er et af de mest populære virksomheder på Eulerpool.com.

Hyppigt stillede spørgsmål om Starsource Multitrade aktie

Pris til håndgribeligt bogført værdi (P/TBV) for Starsource Multitrade er 13,16 i 2026.

Pris til håndgribeligt bogført værdi (P/TBV) for Starsource Multitrade ændrede sig fra 1,29 til 13,16, hvilket repræsenterer en ændring på 919,24 %. Værdien er højere end i foregående år.

På Eulerpool kan du finde den fuldstændige historiske udvikling af Pris til håndgribeligt bogført værdi (P/TBV) Starsource Multitrade siden 2006 – med årlige værdier, diagrammer og detaljeret analyse.

P/TBV sammenligner aktiekursen med håndgribelig bogført værdi pr. aktie, eksklusive goodwill og immaterielle aktiver. Det giver en konservativ værdiansættelse baseret på aktiver.

For at evaluere Pris til håndgribeligt bogført værdi (P/TBV)s er det afgørende at sammenligne det med andre virksomheder i samme branche og sektor. På Eulerpool kan du finde branchsammenligninger for Pris til håndgribeligt bogført værdi (P/TBV).

En 'god' varierer efter branche og virksomhedens udviklingsstadium. På Eulerpool kan du sammenligne Pris til håndgribeligt bogført værdi (P/TBV)s Starsource Multitrade med konkurrenter og branchegjennemsnittet for at afgøre, om den er attraktiv.

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

Værdiansættelse — Starsource Multitrade

Alle nøgletal — Starsource Multitrade